Veterans’ mental health and housing improved when they accessed free legal services in a Veterans Affairs facility, according to a study of veterans in Connecticut and New York City. The more legal services they had, the better they fared, experiencing reduced symptoms of Post-Traumatic Stress Disorder (PTSD) and psychosis, spending less money on abused substances and having better housing situations, the study found. In addition, the study concluded that mental health was improved even if veterans lost their legal battles. The study analyzed the legal/medical partnerships between the nonprofit Connecticut Veterans Legal Center (CVLC) and VA Connecticut Healthcare and between New York Legal Assistance and two VA hospitals. It looked at free legal help given to 950 veterans from 2014 through 2016 and its effects on the mental health, housing, and income of 148 of those veterans followed closely for a year.
Frustrated by Pentagon efforts, Connecticut groups that work with veterans have informed some 1,500 veterans that they can apply for upgrades of “bad paper” military discharge statuses if they have been diagnosed with Post Traumatic Stress Disorder (PTSD). Although tens of thousands of veterans nationwide are eligible to apply for PTSD-related upgrades, just 1,180 have done so, according to figures provided by the Pentagon to the Yale Law School Veterans Legal Services Clinic. In 2014, then Defense Secretary Chuck Hagel issued a policy to make it easier for veterans with PTSD to upgrade their discharge statuses and become eligible for veterans’ benefits. “Most people don’t know about it,” said Olivia Horton, a Yale law student, working on the project to contact Connecticut veterans by mail. She said frustration with the Pentagon’s public outreach “was the impetus” to contact veterans directly.
Now is the time to repeal a 40-year-old law that perpetuates inequality among women. The Hyde Amendment, which bans the use of federal funds to pay for abortions except in certain circumstances, is unfair. The amendment targets women who rely on Medicaid for their health care coverage. According to the federal Centers for Medicare and Medicaid Services, roughly two out of three adult women enrolled in Medicaid are between the ages of 19 and 44—the reproductive years. Abortions can run upward of $1,000, which places the (legal) procedure out of reach for most women living in poverty.
Michael Baudin of Manchester retired eight years ago after a career in auto repair, but now the 76-year-old is back working part time as a driver so he can afford prescription medications. “Every year premiums go up and my co-pay is increasing,” he said. “I take medication for cholesterol, hypertension, heart, prostate and digestion. My wife quit her job due to health issues and her medication is expensive too.”
Baudin says his out-of-pocket cost for a 90-day supply of just one drug, Creon from AbbVie Inc., which he takes for digestion, is $100. The drug does not have a generic equivalent.
In hospitals across Connecticut and nationwide, workarounds to compensate for medication shortages are daily routines for treating patients – and health experts say it’s not about to change any time soon. Some acute-care drugs in short supply nationally are antibiotics, antipsychotics, intravenous saline, and morphine, according to the most recent shortage list from the U.S. Food and Drug Administration. In Connecticut, hospital officials say they are turning to alternative drugs, rationing supplies, or seeking new suppliers to work around the shortages. At St. Francis Hospital and Medical Center in Hartford, Dr. C. Steven Wolf, chief of emergency medicine, said doctors most recently have been dealing with shortages of dextrose, used to treat dehydration and low blood sugar, as well as intravenous saline and other basic medications.
Five Connecticut physicians have received letters from the U.S. Food and Drug Administration (FDA) alleging that they may have purchased unapproved drugs that put patients at risk of adverse health consequences, documents obtained by C-HIT show. The FDA documents show the five doctors were alerted as part of a wide-reaching federal probe involving Gallant Pharma International Inc., which sold more than $12.4 million in unapproved chemotherapy and injectable cosmetic drugs in the United States before the government shut down the operation in 2013. The letters to the doctors, dated April 1, 2015, say that “In addition to putting patients at risk, receiving misbranded or adulterated drugs and devices in interstate commerce and delivering or offering to deliver those drugs and devices to (or use on) others violates federal law.”
None of the doctors has been charged with wrongdoing, and only one acknowledged receiving the letter from the FDA. The case comes to light as drug companies and pharmacies are urging Congress and law enforcement officials to crack down on an increasing number of dangerous unapproved and counterfeit drugs being sold to doctors and consumers nationwide. Sales of counterfeit drugs and drugs not approved by FDA have soared into a multi-billion dollar industry with the growth of the Internet, and drug companies say efforts by governments to tackle illegal online drug sales are not sufficient.
Citing the escalating incidence of opioid addiction and overdoses in Connecticut, U.S. Sen. Richard Blumenthal said Monday that the state needs a “comprehensive, multifaceted” approach to combat the problem and identify areas in which federal funds might support those efforts. More than a dozen educators, physicians, law-enforcement representatives, substance-abuse experts, public-health professionals, and members of advocacy groups joined Blumenthal at the standing-room-only event at the offices of Community Mental Health Affiliates in New Britain. Also attending were two young adults who were in recovery after years of addiction that led to their incarceration and eventual treatment, along with a mother who lost her 26-year-old son to an overdose. “Drug addiction among young people is a horrendous and life-threatening epidemic – a deadly epidemic, as we have seen in the last few days,” Blumenthal said, referring to the nine heroin overdoses, one of them fatal, that occurred in New London County this past weekend. Blumenthal said that educators, physicians, social services and lawmakers must work together.
The Centers for Medicare and Medicaid Services has backed off a controversial plan that would have changed the way it determines Medicare coverage for advanced prosthetics – a plan critics said would have affected tens of thousands of veterans nationwide. CMS had issued a draft proposal, known as a Local Coverage Determination for Lower Limb Prostheses, that critics feared would limit access to prosthetics for amputees, including veterans. Following a public comment period that ended in August and a review of those comments, CMS on Monday announced it would not finalize the draft policy. “Both CMS and its contractors have heard concerns about access to prostheses for Medicare beneficiaries,” according to a statement provided by CMS spokeswoman Helen Mulligan. CMS said it would convene a work group in 2016 to examine the lower limb prostheses issue.
Very few veterans take advantage of a Pentagon policy designed to make it easier for veterans with Post Traumatic Stress Disorder (PTSD) to upgrade their discharge status and become eligible to apply for veterans’ benefits, according to a Yale Law Clinic report. At a news conference Monday, U.S. Sen. Richard Blumenthal, D-Conn., veterans, and Yale law students, blamed the Department of Defense for not adequately publicizing the policy to veterans with less than honorable discharges. Since new guidelines were announced last year, just 201 of tens of thousands of eligible veterans applied for a PTSD-related service upgrade, according to the report. Blumenthal called the statistic “a staggering, outrageous fact.”
“Veterans on the streets of New Haven or Connecticut or the rest of the country have no idea about this,” Blumenthal said. “It takes a vigorous and rigorous effort, which the DOD committed to and they have failed,” he added.
US Sen. Richard Blumenthal (D-Conn.) and U.S. Sen. Chuck Grassley (R-Iowa) have introduced legislation that would require drug companies and medical device manufacturers to start reporting their payments to nurse practitioners and physician assistants, as they do for physicians. “Requiring companies to disclose gifts and payments made to other health care providers – not just doctors – is absolutely essential,” Blumenthal said in a statement Tuesday. “The Provider Patient Sunshine Act will rein in dishonorable behavior by increasing transparency and accountability across the entire healthcare industry.”
Grassley added: “It makes sense to apply the sunshine (provisions) to anyone who prescribes medicine.”
The proposed Provider Payment Sunshine Act, would require drug companies and device makers to publicly disclose payments to nurse practitioners and physician assistants for promotional talks, consulting and other services. The companies already report such payments to physicians in a national Open Payments database, under prior legislation co-authored by Grassley. The payments to nurse practitioners and physician assistants would be added to that database. Nurse practitioners and physician assistants write a significant number of prescriptions in the federal Medicare program, data show.